Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hypoxia × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Motor Activity 201 Breast Neoplasms 111 Neoplasms 88 Prostatic Neoplasms 33 Fatigue 28 Obesity 22 Colorectal Neoplasms 19 Lung Neoplasms 16 Colonic Neoplasms 15 Polycystic Ovary Syndrome 14 Ovarian Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma 10 Lymphedema 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Weight Loss 8 Multiple Myeloma 8 Leukemia 8 Hematologic Neoplasms 8 Cardiotoxicity 8 Pancreatic Neoplasms 7 Insulin Resistance 7 Carcinoma, Non-Small-Cell Lung 7 Cognitive Dysfunction 6 Brain Neoplasms 6 Overweight 5 Inflammation 5 Cachexia 5 Stomach Neoplasms 4

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 5 pimonidazole 4 fluoroazomycin arabinoside 4 Radiotherapy 3 Injections 3 Propofol 2 gadobutrol 1 fludarabine 1 alovudine 1 Thoracotomy 1 Thoracic Surgery, Video-Assisted 1 Temozolomide 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Saline Solution 1 Pancreaticoduodenectomy 1 Oxygen 1 Nitroglycerin 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Letrozole 1 Hydroxychloroquine 1 Gemcitabine 1 Furosemide 1 Ferrosoferric Oxide 1 Exercise 1 Dexmedetomidine 1 Cyclophosphamide 1 Circulating Tumor DNA 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03365076 2023-01-09

EXIPOX

University Hospital of North Norway

Phase NA Terminated

Hypoxia, Motor Activity, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡